AORT
Price
$40.42
Change
-$0.01 (-0.02%)
Updated
Sep 26, 12:56 PM (EDT)
Capitalization
1.91B
34 days until earnings call
BIAF
Price
$5.92
Change
+$2.51 (+73.61%)
Updated
Sep 26, 12:59 PM (EDT)
Capitalization
4.56M
47 days until earnings call
Interact to see
Advertisement

AORT vs BIAF

Header iconAORT vs BIAF Comparison
Open Charts AORT vs BIAFBanner chart's image
Artivion
Price$40.42
Change-$0.01 (-0.02%)
Volume$661
Capitalization1.91B
bioAffinity Technologies
Price$5.92
Change+$2.51 (+73.61%)
Volume$12.84K
Capitalization4.56M
AORT vs BIAF Comparison Chart in %
Loading...
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AORT vs. BIAF commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AORT is a Buy and BIAF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (AORT: $40.43 vs. BIAF: $3.41)
Brand notoriety: AORT and BIAF are both not notable
AORT represents the Medical/Nursing Services, while BIAF is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AORT: 85% vs. BIAF: 188%
Market capitalization -- AORT: $1.91B vs. BIAF: $4.56M
AORT [@Medical/Nursing Services] is valued at $1.91B. BIAF’s [@Medical Specialties] market capitalization is $4.56M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.02B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.49B. The average market capitalization across the [@Medical Specialties] industry is $10.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AORT’s FA Score shows that 0 FA rating(s) are green whileBIAF’s FA Score has 0 green FA rating(s).

  • AORT’s FA Score: 0 green, 5 red.
  • BIAF’s FA Score: 0 green, 5 red.
According to our system of comparison, AORT is a better buy in the long-term than BIAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AORT’s TA Score shows that 3 TA indicator(s) are bullish while BIAF’s TA Score has 4 bullish TA indicator(s).

  • AORT’s TA Score: 3 bullish, 5 bearish.
  • BIAF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BIAF is a better buy in the short-term than AORT.

Price Growth

AORT (@Medical/Nursing Services) experienced а -2.25% price change this week, while BIAF (@Medical Specialties) price change was -32.78% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.15%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +9.32%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.65%. For the same industry, the average monthly price growth was +2.63%, and the average quarterly price growth was +23.73%.

Reported Earning Dates

AORT is expected to report earnings on Oct 30, 2025.

BIAF is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Medical/Nursing Services (-2.15% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Medical Specialties (-2.65% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AORT($1.91B) has a higher market cap than BIAF($4.56M). AORT YTD gains are higher at: 41.413 vs. BIAF (-87.509). AORT has higher annual earnings (EBITDA): 39.8M vs. BIAF (-11M). BIAF has less debt than AORT: BIAF (670K) vs AORT (264M). AORT has higher revenues than BIAF: AORT (405M) vs BIAF (7.68M).
AORTBIAFAORT / BIAF
Capitalization1.91B4.56M41,815%
EBITDA39.8M-11M-362%
Gain YTD41.413-87.509-47%
P/E RatioN/AN/A-
Revenue405M7.68M5,273%
Total Cash53.5MN/A-
Total Debt264M670K39,403%
FUNDAMENTALS RATINGS
AORT: Fundamental Ratings
AORT
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
48
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
75
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AORTBIAF
RSI
ODDS (%)
Bearish Trend 1 day ago
62%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBSDX52.17N/A
N/A
Franklin S&P 500 Index D
MIGDX33.35N/A
N/A
MFS Massachusetts Inv Gr Stk C
NBNGX26.26N/A
N/A
Sit Mid Cap Growth
LVAMX11.47N/A
N/A
LSV US Managed Volatility Investor
DWGHX13.53-0.07
-0.51%
American Funds Dvlpg Wld Gr&Inc F2

AORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, AORT has been loosely correlated with TCMD. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then TCMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AORT
1D Price
Change %
AORT100%
-1.17%
TCMD - AORT
43%
Loosely correlated
-2.80%
VREX - AORT
42%
Loosely correlated
-2.45%
LMAT - AORT
42%
Loosely correlated
-3.58%
SONVY - AORT
42%
Loosely correlated
-4.07%
SYK - AORT
41%
Loosely correlated
-0.71%
More

BIAF and

Correlation & Price change

A.I.dvisor tells us that BIAF and SNWV have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIAF and SNWV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIAF
1D Price
Change %
BIAF100%
-20.51%
SNWV - BIAF
32%
Poorly correlated
-3.03%
HSCS - BIAF
29%
Poorly correlated
+1.36%
RDNT - BIAF
26%
Poorly correlated
-0.56%
AORT - BIAF
22%
Poorly correlated
-1.17%
TCMD - BIAF
21%
Poorly correlated
-2.80%
More